| Literature DB >> 29311493 |
Aprilia Maharani1, Keisuke Aoshima1, Shinichi Onishi1, Kevin Christian Montecillo Gulay1, Atsushi Kobayashi1, Takashi Kimura1.
Abstract
Canine hemangiosarcoma (HSA) is one of the most common mesenchymal tumors in dogs. Its high metastatic and growth rates are usually associated with poor prognosis. Neoplastic cells of HSA can show various levels of cellular atypia in the same mass and may consist of various populations at different differentiated stages. Up to present, however, there is no report analyzing their differentiation states by comparing cellular atypia with differentiation-related protein expressions. To evaluate whether cellular atypia can be used as a differentiation marker in HSA, we analyzed correlation between cellular atypia and intensities of CD31 and von Willebrand Factor (vWF) staining in HSA cases. We also compared cellular atypia and expression levels of CD31 and vWF in each growth patterns. Our results show that cellular atypia was negatively correlated to CD31 and vWF expression levels but no significant correlation was found between growth patterns and cellular atypia or CD31 and vWF expression levels. Our study suggests that cellular atypia is useful for identifying differentiation levels in HSA cases. This study also provides useful information to determine differentiation levels of cell populations within HSA based only on morphological analysis, which will aid further HSA research such as identifying undifferentiation markers of endothelial cells or finding undifferentiated cell population in tissue sections.Entities:
Keywords: CD31; canine hemangiosarcoma; cellular atypia; growth pattern; vWF
Mesh:
Substances:
Year: 2018 PMID: 29311493 PMCID: PMC5836755 DOI: 10.1292/jvms.17-0561
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Case information and scores
| No | Breed | Age | Sex | Location | Histological growth pattern | Cellular Atypia | CD31 | vWF | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capa) | Cavb) | Solc) | Capa) | Cavb) | Solc) | Capa) | Cavb) | Solc) | ||||||
| 1 | Labrador retriever | 10y | Spayed female | Spleen | Solid | 1 | 3 | 2 | ||||||
| Liver | Solid | 1 | 2 | 2 | ||||||||||
| 2 | Border Collie | 13y | Male | Spleen | Predominantly cavernous, partly solid | 2 | 2 | 1 | 2 | 1 | 1 | |||
| 3 | Maltese | 10y | Male | Spleen | Solid, Capillary, Cavernous | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| 4 | Golden retriever | 11y | Male | Spleen | Predominantly cavernous, partly capillary | 1 | 2 | 2 | 0 | 0 | 0 | |||
| 5d) | Scottish terrier | 11y | Spayed female | Thoracic cavity | Predominantly capillary, partly cavernous | 3 | 3 | 2 | 0 | 0 | 1 | |||
| 3 | 3 | 2 | 2 | 0 | 0 | |||||||||
| 6 | Miniature dachshund | 10y | Female | Liver | Solid | 2 | 3 | 1 | 1 | 1 | 0 | |||
| Spleen | Solid | 2 | 3 | 1 | 2 | 1 | 0 | |||||||
| 7d) | Labrador retriever | 13y | Male | Spleen | Capilary and Cavernous | 3 | 3 | 1 | 1 | 0 | 0 | |||
| 2 | 3 | 2 | 1 | 1 | 0 | |||||||||
| 8 | Miniature schnauzer | 9y | Male | Spleen | Predominantly cavernous, partly capillary | 3 | 3 | 1 | 1 | 0 | 0 | |||
| 9d) | Golden retriever | 9y | Spayed female | Spleen | Solid | 2 | 1 | 2 | ||||||
| 2 | 3 | 0 | ||||||||||||
| 10d) | Miniature schnauzer | 11y | Male | Spleen | Capillary | 2 | 2 | 2 | ||||||
| 3 | 0 | 1 | ||||||||||||
| 11 | Miniature dachshund | 9y | Female | Spleen | Predominantly solid, partly cavernous | 2 | 2 | 1 | 0 | 3 | 0 | |||
| 12 | French bulldog | 5y | Male | Spleen | Predominantly cavernous, partly capillary | 2 | 2 | 1 | 0 | 0 | 0 | |||
| 13 | Golden retriever | 9y | Castrated Male | Liver | Predominantly capillary, partly cavernous | 3 | 3 | 0 | 0 | 0 | 0 | |||
| Spleen | Capillary and cavernous | 3 | 3 | 1 | 1 | 0 | 0 | |||||||
| 14d) | Bichon frise | 8y | Spayed female | Kidney | Predominantly capillary, partly cavernous | 2 | 1 | 1 | 0 | 0 | 0 | |||
| 3 | 1 | 1 | 0 | 0 | 0 | |||||||||
| 15 | Jack russel terrier | 7y | Male | Spleen | Cavernous | 2 | 1 | 2 | ||||||
| Liver | Cavernous | 2 | 1 | 2 | ||||||||||
| 16d) | Labrador retriever | 10y | Male | Spleen | Predominantly solid | 2 | 0 | 0 | ||||||
| 1 | 1 | 0 | ||||||||||||
| 17d) | Great pyrenees | 10y | Castrated Male | Spleen | Solid | 1 | 3 | 3 | ||||||
| 2 | 1 | 2 | ||||||||||||
| 3 | 1 | 0 | ||||||||||||
All scores were given to each population in the slides. a) Cap=population which showed capillary growth pattern. b) Cav=population which showed cavenous growth pattern. c) Sol=population which showed solid growth pattern. d) Scores were given to each populations which showed different morphology and/or immunoreactivity.
Fig. 1.Representative figures of cellular atypia (A), CD31 expression levels (B) and vWF expression levels (C). Inserted images are the magnified views of each figures. Rectangle images at the bottom of (B) and (C) are immunohistochemical reactivity of CD31 and vWF in normal endothelial cells in the same slides of above images. Bars=20 µm.
Fig. 2.Association between (A) cellular atypia and CD31, (B) cellular atypia and vWF, and (C) CD31 and vWF. R: Pearson’s correlation coefficient. The immunohistochemical reactivity of CD31 and vWF were scored as negative=0, mild=1, moderate=2 and high=3. Cellular atypia levels were scored as mild=1, moderate=2 and severe=3.
Fig. 3.Expression levels of CD31 (A) and vWF (B), and cellular atypia scores (C) in each growth pattern. Kruskal wallis test was done for statistical analysis. The immunohistochemical reactivity of CD31 and vWF were scored as negative=0, mild=1, moderate=2 and high=3. Cellular atypia levels were scored as mild=1, moderate=2 and severe=3.